Clinical research in Europe is changing in big ways. Studies are becoming more complex, rules and regulations are constantly shifting, and sponsors are under pressure to bring new treatments to patients faster while keeping safety and quality front and center. But through all this, what matters most are the patients. They are more informed, more engaged, and more involved than ever before. They want research that understands their lives, respects their time, and puts their needs at the heart of every decision.
The people who make these trials happen depend on specialty laboratory services to do their part. Labs may work behind the scenes, but their work affects patients every day. From tracking biomarkers to validating tests, every sample, every result, and every measurement influences how a trial is run and how participants are cared for. The work of these labs can mean the difference between a smooth, safe experience for a patient and unnecessary delays or uncertainty. In personalized, data-driven research, this human impact is what matters most.
The patients are what drive every choice and action. Every test, every procedure, every data point represents a person placing trust in the research process. Researchers and clinical teams dedicate themselves to understanding those patients, listening to their needs, and applying their expertise to guide care safely. Maria Fotiu, Managing Director at Cerba Research, describes her approach as deeply rooted in this patient focus, balancing scientific rigor with a commitment to the people who make the research possible.
Let’s take a closer look at leadership driving precision, trust, and innovation in modern clinical research!
A Career That Began with Patients
Maria’s path into clinical research did not start with a leadership title or a strategic role. It started on the ground, working directly with patients and investigators. As she explains, “I began my clinical research journey as a study coordinator while I was still in university executing clinical trials with principal investigators and working directly with patients.” Those early experiences shaped how she views research to this day.
Working closely with patients provided firsthand insight into the responsibility carried by everyone involved in a clinical trial. It was not just about protocols or timelines. It was about people placing trust in the research process. That understanding stayed with her as she moved into full-service contract research organizations after completing her studies.
Her career progressed through roles that allowed her to collaborate with biotech and pharmaceutical companies, deliver complex trials, engage investigators, and refine how studies are conducted. Along the way, she gained exposure to process improvement, organizational leadership, and the operational realities of clinical development. Each role added another layer of perspective.
Reflecting on where those experiences led her, she shares, “Cerba Research is the culmination of those experiences in the clinical research industry where I have the opportunity to focus on the laboratory services, driving with scientific expertise, and contributing to the end-to-end drug and device development processes.”
Leading with Trust, Transparency, and Space
Leadership in a clinical trial lab services environment requires balance. There must be clear direction, but also room for teams to apply their expertise and judgment. For Maria, transparency is the foundation of effective leadership. She believes teams perform best when they understand where the organization is headed and why.
As she describes it, “I believe in transparency and ensuring the team has clear vision of our business plans, while giving my functional leaders the responsibility to determine how we will get there.” This approach creates accountability without micromanagement. Leaders are given a framework and clear expectations, but they are trusted to determine the best path forward.
This way of working recognizes that there is rarely only one solution to a problem. By allowing different approaches, teams are encouraged to think creatively and take ownership of outcomes. It also helps foster innovation at all levels of the organization.
Importantly, innovation is not defined only by technology investments. As Maria explains, “Innovation is often confused with investment and technology, whereas for Cerba Research it is process optimization, service enhancement, and infusion of science in everything that we do to deliver laboratory services that meet and exceed the customers expectations.” This mindset keeps innovation practical and closely tied to client and patient needs.
The Growing Importance of Specialty Laboratory Services
As clinical research becomes more complex, the role of specialty laboratory services continues to expand. Personalized medicine is reshaping how therapies are developed, moving away from one-size-fits-all approaches toward treatments guided by biomarkers and precise patient insights. This shift places specialty testing at the center of clinical development, providing the molecular, genomic, immunologic, and functional data needed to understand disease and predict how patients may respond to treatment.
In vitro diagnostics now require careful consideration of validation and certification requirements across different regions, often early in the development process. Biomarkers play an increasingly important role in diagnosis, treatment decisions, and monitoring patient responses. Digital biomarkers are also gaining momentum, offering new ways to track disease progression and therapeutic effect, and becoming a realistic option in research and development programs.
As pipelines increasingly focus on complex modalities such as cell and gene therapies, immunotherapies, rare disease treatments, and multiomics driven studies, specialty laboratory services are no longer simply supportive. They help shape study design, define patient inclusion criteria, and contribute to decisions that influence regulatory pathways and future access.
Artificial intelligence is another factor shaping the future of laboratory services. Its ability to support deeper evaluation of large and complex data sets is changing how diagnostic and biomarker information is interpreted. When applied thoughtfully and transparently, and in alignment with regulatory expectations, it helps sponsors make more informed decisions with greater confidence.
By focusing on these areas, the organization positions itself to support sponsors from the earliest phases of development. Early engagement enables better planning, stronger alignment, and the flexibility to adapt as programs evolve. This approach strengthens long term partnerships and supports the shared goal of delivering targeted therapies to patients faster.
Building Quality into Everything
Quality has always been a priority in clinical research, but its true impact depends on how deeply it is embedded in daily work. Under current leadership, there has been a strong focus on making quality a shared responsibility across the organization. As Maria explains, “We are continually focused on quality and inspection readiness, but have really focused on ensuring that quality is deeply infused across the organization.”
This emphasis became even more important following several acquisitions. Cerba Research is the result of multiple organizations coming together, each with its own processes and strengths. In 2025, significant effort was dedicated to harmonizing and integrating functions while respecting the contributions each team brought to the table.
At the same time, attention was given to the IT landscape. Systems and applications were reviewed to ensure they supported processes rather than controlled them. The goal was to enable teams to do their work effectively without being constrained by technology. This balance is essential in an environment where scientific judgment and human oversight remain critical.
Keeping the Patient at the Center
Despite the complexity of systems, data, and operations, there is a consistent reminder throughout the organization of why the work matters. From her first day, Maria emphasized the connection between laboratory work and patient lives. As she puts it, “From the day I arrived at Cerba Research, I’ve stressed the importance of remembering that each lab tube, each biopsy specimen, and each lab test represents a patient.”
This perspective helps teams stay grounded. It reinforces the idea that behind every sample and every data point is a person waiting for answers, treatment options, or hope. By keeping patients front of mind, quality and accountability take on deeper meaning.
Supporting accelerated drug discovery and development is not an abstract goal. It is a mission tied directly to improving patient lives. Even as a specialty service provider, the organization understands that its work can influence enrollment, retention, treatment decisions, and safety assessments throughout a trial.
Responding to Market Uncertainty
The past few years have been challenging for the clinical research industry. Uncertainty in R&D spending has led many biotech and pharmaceutical companies to pause or adjust development plans. Shifts in therapeutic focus and questions around how to best use artificial intelligence have added to the complexity.
Navigating this environment requires careful positioning. Cerba Research has taken a methodical approach, focusing on areas where it can provide the most value as a specialty laboratory services partner. Supporting customers from early development stages allows for closer collaboration and greater flexibility.
There is also a continuous review of therapeutic expertise and service offerings to ensure readiness for emerging needs. AI is being incorporated thoughtfully, both in support functions and in analytics and modeling that assist customers with their development strategies.
Partnerships That Go Beyond Transactions
Strong partnerships are essential to successful clinical trials. Long-term relationships with sponsors, biotech companies, and healthcare institutions form the foundation of the organization’s work. A customer-centric mindset guides both service delivery and the development of new offerings.
The focus is on making collaboration easier, from early pipeline discussions to ongoing trial support. As Maria explains, “At each step, we are thinking about the patient, and by extension the institutions enrolling those patients, so we can reduce burden on them. Every decision is viewed through the lens of how it affects those involved in the trial.”
For key partnerships, dedicated senior leaders oversee activities, monitor performance, and maintain regular engagement with customer leadership teams. These relationships are nurtured proactively, not only when challenges arise. Leadership team members are encouraged to stay closely connected with both internal teams and customers.
Commitment to Inclusivity
While the organization does not enroll patients directly, it supports inclusivity in clinical research through laboratory services that consider population diversity. Ensuring that data reflects varied populations is essential for accurate and meaningful outcomes.
Internally, there is a strong commitment to diversity and inclusion. Recruitment processes emphasize balanced candidate slates and focus on placing the right skills in the right roles at the right time. The goal is to build teams that reflect the patients ultimately served and bring diverse perspectives to problem solving.
Lessons from a High-Stakes Environment
Leading in a fast-paced and high-stakes environment has reinforced several important lessons. At the top of the list is clarity. As Maria notes, “Transparency, respect and a focus on the customer are key.” Teams need the right information to guide decisions, and customers need honest communication about capabilities and timelines.
Being open about what can and cannot be done builds trust. Adopting a “yes, and” approach allows risks to be acknowledged while exploring alternative solutions. This mindset helps set realistic expectations and supports long-term success.
Mistakes are inevitable in a service-driven business. What matters is how they are addressed. Curiosity, empathy, and a commitment to resolution define trusted partnerships.
Advice for the Next Generation
For young professionals entering clinical research, there is no single path to leadership. Growth comes from both depth and breadth of experience, as well as learning from failures. Exposure to different roles helps shape a well-rounded leadership style.
Respect is essential throughout the journey. Bringing people along as careers progress is just as important as individual advancement. Mentorship can play a defining role. For Maria, one question from an early mentor continues to resonate: “Do you want to be a leader your team will get into the foxhole with, or a leader they’ll also get into the foxhole for?” The answer shapes how leadership is practiced every day.
